Literature DB >> 4354859

Enzyme loading of erythrocytes.

G M Ihler, R H Glew, F W Schnure.   

Abstract

We demonstrated that beta-glucosidase and beta-galactosidase can be trapped inside erythrocytes by rapid hemolysis of the cell in the presence of these enzymes. Enzyme enters only during hemolysis, and optimum uptake occurs within 60 sec. There is no loss in cell number after hemolysis-induced enzyme uptake, and the ghosts have only a slightly increased mean cell volume. Smaller proteins enter more readily than larger proteins, although enzymes with a molecular weight of at least 180,000 can be readily entrapped by erythrocytes. This finding may provide a useful approach to the problem of enzyme replacement in certain diseases, including Gaucher's disease.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4354859      PMCID: PMC427078          DOI: 10.1073/pnas.70.9.2663

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Studies on the extracellular alkaline phosphatase of Micrococcus sodonensis. I. Isolation and characterization.

Authors:  R H Glew; E C Heath
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

3.  The fine structure of the cerebroside occurring in Gaucher's disease.

Authors:  R E Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

4.  Composition of the membranous deposits occurring in Gaucher's disease.

Authors:  R H Glew; R E Lee
Journal:  Arch Biochem Biophys       Date:  1973-06       Impact factor: 4.013

5.  L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.

Authors:  C M Haskell; G P Canellos; B G Leventhal; P P Carbone; J B Block; A A Serpick; O S Selawry
Journal:  N Engl J Med       Date:  1969-11-06       Impact factor: 91.245

Review 6.  Destruction of injured red cells in vivo.

Authors:  R A Rifkind
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

7.  Entry of ferritin into human red cells during hypotonic haemolysis.

Authors:  R F Baker
Journal:  Nature       Date:  1967-07-22       Impact factor: 49.962

8.  Transient holes in the erythrocyte membrane during hypotonic hemolysis and stable holes in the membrane after lysis by saponin and lysolecithin.

Authors:  P Seeman
Journal:  J Cell Biol       Date:  1967-01       Impact factor: 10.539

9.  The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.

Authors:  E Beutler; W Kuhl
Journal:  J Lab Clin Med       Date:  1970-11

10.  Physiological characteristics of human red blood cell ghosts.

Authors:  J F HOFFMAN
Journal:  J Gen Physiol       Date:  1958-09-20       Impact factor: 4.086

View more
  48 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Nano-intercalated organophosphorus-hydrolyzing enzymes in organophosphorus antagonism.

Authors:  Ilona Petrikovics; Melinda Wales; Marianna Budai; Jorn C C Yu; Mária Szilasi
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

Review 3.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

Review 4.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 5.  Targeted therapeutics and nanodevices for vascular drug delivery: quo vadis?

Authors:  Vladimir R Muzykantov
Journal:  IUBMB Life       Date:  2011-06-30       Impact factor: 3.885

Review 6.  Advancing drug delivery systems for the treatment of multiple sclerosis.

Authors:  Inna Tabansky; Mark D Messina; Catherine Bangeranye; Jeffrey Goldstein; Karen M Blitz-Shabbir; Suly Machado; Venkatesh Jeganathan; Paul Wright; Souhel Najjar; Yonghao Cao; Warren Sands; Derin B Keskin; Joel N H Stern
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 7.  Erythrocyte-mediated delivery of recombinant enzymes.

Authors:  Vincenzo Leuzzi; Luigia Rossi; Claudia Gabucci; Francesca Nardecchia; Mauro Magnani
Journal:  J Inherit Metab Dis       Date:  2016-03-30       Impact factor: 4.982

8.  Organic-acid transport in resealed haemoglobin-containing human erythrocyte 'ghosts'.

Authors:  A R Hubbard; U Sprandel; R A Chalmers
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

Review 9.  Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.

Authors:  Bishnu P Joshi; Joseph Hardie; Michelle E Farkas
Journal:  Chemistry       Date:  2018-05-14       Impact factor: 5.236

10.  In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes.

Authors:  Yinxing Liu; Hanjun Guan; Tina L Beckett; Maria Aparecida Juliano; Luiz Juliano; Eun Suk Song; K Martin Chow; M Paul Murphy; Louis B Hersh
Journal:  Peptides       Date:  2007-09-29       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.